Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide in Poor Responders Undergoing IVF
NCT02262923Withdrawn
- Sponsor
- Mount Sinai Hospital
- Start
- Mar 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of metoclopramide in poor ovarian response (POR) (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Number of oocytes retrieved at 1 year. Planned start Mar 2016; status: withdrawn.
02
Drugs
metoclopramide
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT02262923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262923.